Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy

Data on the proper post-surgical chemotherapy (PSC) in pancreatic ductal adenocarcinoma (PDAC) patients already treated with neoadjuvant therapy (NAT) are lacking, especially for stage ypIA.

Source: Digestive and Liver Disease - July 15, 2023 Category: Gastroenterology Authors: Marina Macchini, Giulio Belfiori, Stefano Crippa, Giulia Orsi, Giulia Gasparini, Domenico Tamburrino, Stefano Partelli, Marco Schiavo Lena, Diego Palumbo, Francesco De Cobelli, Massimo Falconi, Michele Reni Tags: Oncology Source Type: research